These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 19595511)

  • 1. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.
    Zhou Q; Zhang B; Verne GN
    Pain; 2009 Nov; 146(1-2):41-6. PubMed ID: 19595511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal hypersensitivity in a subset of irritable bowel syndrome patients.
    Zhou Q; Fillingim RB; Riley JL; Verne GN
    World J Gastroenterol; 2009 Jul; 15(26):3254-60. PubMed ID: 19598301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
    Xu X; Liu L; Yao S; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome.
    Wilder-Smith CH; Robert-Yap J
    World J Gastroenterol; 2007 Jul; 13(27):3699-704. PubMed ID: 17659729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
    Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to cutaneous thermal nociceptive stimuli in irritable bowel syndrome.
    Rodrigues AC; Nicholas Verne G; Schmidt S; Mauderli AP
    Pain; 2005 May; 115(1-2):5-11. PubMed ID: 15836964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients.
    Liu L; Liu BN; Chen S; Wang M; Liu Y; Zhang YL; Yao SK
    J Zhejiang Univ Sci B; 2014 Oct; 15(10):907-14. PubMed ID: 25294380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral hypersensitivity in the irritable bowel syndrome.
    Zhou Q; Fillingim RB; Riley JL; Malarkey WB; Verne NG
    Pain; 2010 Mar; 148(3):454-461. PubMed ID: 20074857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC
    Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
    Camilleri M; Lasch K; Zhou W
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational evaluation of Gelsectan
    Inczefi O; Eutamene H; Placide F; Tondereau V; Pallagi P; Bagyánszki M; Bódi N; Gémes N; Szebeni G; Molnár T; Theodorou V; Róka R
    United European Gastroenterol J; 2024 Oct; 12(8):1102-1113. PubMed ID: 39106086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic hypersensitivity in irritable bowel syndrome patients.
    Zhou Q; Fillingim RB; Riley JL; Verne GN
    Pain Med; 2010 Nov; 11(11):1619-27. PubMed ID: 21029350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors.
    Verne GN; Price DD; Callam CS; Zhang B; Peck J; Zhou Q
    J Pain; 2012 Sep; 13(9):901-9. PubMed ID: 22958874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E
    Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome.
    Piché M; Arsenault M; Poitras P; Rainville P; Bouin M
    Pain; 2010 Jan; 148(1):49-58. PubMed ID: 19889500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.